Chemed (CHE) vs PACS Group (PACS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
PACS Group (PACS) has outperformed Chemed (CHE) over the past year, gaining 224.7% versus a gain of 15.0%. PACS Group is the larger company by market cap ($6.80 billion vs $6.49 billion), about 1.0 times the size. On valuation, PACS Group trades at a lower forward P/E (15.7x vs 18.1x for Chemed).
Chemed pays a dividend yielding 0.48%, while PACS Group does not currently pay one. Chemed converts more of its revenue into profit, with a net margin of 10.5% versus 3.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CHE | PACS |
|---|---|---|
| Share price | $496.80 | $42.93 |
| Market cap | $6.49B | $6.80B |
| 1-day change | -0.93% | -0.60% |
| YTD return | +17.20% | +12.50% |
| 1-year return | +14.99% | +224.74% |
| 5-year return | +16.58% | — |
| P/E ratio (TTM) | 24.99 | 25.11 |
| Forward P/E | 18.05 | 15.72 |
| EPS (TTM) | $19.88 | $1.71 |
| Dividend yield | 0.48% | 0.00% |
| Annual dividend | $2.40 | $0.00 |
| Revenue (latest FY) | $2.53B | $5.29B |
| Revenue growth (YoY) | +4.06% | +29.32% |
| Net income (latest FY) | $265.24M | $191.54M |
| Gross margin | 32.54% | 21.92% |
| Operating margin | 13.37% | 5.85% |
| Net margin | 10.48% | 3.62% |
| 52-week high | $557.00 | $49.49 |
| 52-week low | $365.21 | $10.31 |
| Distance from 52-week high | -10.81% | -13.26% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +15.06% | +37.43% |
| Average volume | 159.79K | 803.44K |
| Shares outstanding | 13.07M | 158.34M |
| Employees | 15,811 | 47,455 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Hospital/Nursing Management |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PACS has outperformed CHE by 209.7 percentage points over the past year.
- Chemed is more profitable, keeping 10.5 cents of every revenue dollar as net income versus 3.6 cents for PACS Group.
- PACS Group grew revenue faster in its latest fiscal year (+29.32% vs +4.06%).
About Chemed
CHE stock →Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments.
Health Care · Medical/Nursing Services · 15,811 employees
About PACS Group
PACS stock →PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities.
Health Care · Hospital/Nursing Management · 47,455 employees
CHE vs PACS FAQ
Which is bigger, Chemed or PACS Group?
PACS Group (PACS) is larger, with a market capitalization of $6.80B compared with $6.49B for Chemed (CHE).
Which stock has performed better over the past year, CHE or PACS?
PACS returned +224.74% over the past 12 months, compared with +14.99% for CHE (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CHE or PACS?
CHE has the lower trailing P/E at 25.0, versus 25.1 for PACS. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Chemed or PACS Group?
Chemed pays a dividend yielding 0.48%, while PACS Group does not currently pay a regular dividend.
Are Chemed and PACS Group in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Nursing Services for Chemed and Hospital/Nursing Management for PACS Group.